These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3674766

  • 1. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
    Strang P, Eklund G, Stendahl U, Frankendal B.
    Anticancer Res; 1987; 7(4B):807-10. PubMed ID: 3674766
    [Abstract] [Full Text] [Related]

  • 2. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P, Stenkvist B, Bergström R, Stendahl U, Valdes del Campo M, Tribukait B.
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [Abstract] [Full Text] [Related]

  • 3. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM.
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP, Miller DS, Bauer KD, Murad TM, Rademaker AW, Lurain JR.
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometry in invasive endometrial carcinoma. Correlations between DNA content S-phase rate and clinical parameters.
    Stendahl U, Wagenius G, Strang P, Tribukait B.
    In Vivo; 1988 Mar; 2(2):123-7. PubMed ID: 2979827
    [Abstract] [Full Text] [Related]

  • 6. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Willén R, Himmelmann A, Långström-Einarsson E, Fernö M, Ranstam J, Baldetorp B, Skjaerris J, Prien-Larsen J, Tropé C, Stendahl U.
    Anticancer Res; 1993 Mar; 13(4):1187-96. PubMed ID: 8352543
    [Abstract] [Full Text] [Related]

  • 7. Differences in DNA content and proliferation rate between adenocarcinomas of the uterine cervix and corpus.
    Strang P, Stendahl U, Lindgren A, Sténson S.
    In Vivo; 1987 Mar; 1(2):109-12. PubMed ID: 2979770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
    Lutgens LC, Schutte B, de Jong JM, Thunnissen FB.
    Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
    [Abstract] [Full Text] [Related]

  • 11. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. A five-year follow up study.
    Volm M, Mattern J, Müller T, Drings P.
    Anticancer Res; 1988 Sep; 8(1):105-12. PubMed ID: 3358625
    [Abstract] [Full Text] [Related]

  • 13. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM, Perrone JF, Stanhope CR, Katzmann JA, Keeney GL, Li H.
    Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
    [Abstract] [Full Text] [Related]

  • 14. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M, Prasad S, Kalra N, Singh U, Shukla Y.
    Oncology; 2006 Oct; 71(5-6):411-6. PubMed ID: 17785995
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T, Izumi S, Yamaoka K, Tsutsui F, Nozawa S.
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H, Fortin A, Bairati I, Morency R, Monteil RA, Têtu B.
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG, Norén H, Delle U.
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of DNA ploidy: 5-year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung.
    Kasprzyk M, Dyszkiewicz W, Piwkowski C, Gasiorowski L, Kaczmarek E.
    Lung Cancer; 2006 Feb; 51(2):201-6. PubMed ID: 16375987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.